secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001493152-25-023444
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric regains Nasdaq minimum bid price compliance; delisting risk removed
---------------------------------------------------------------------------

- Received Nasdaq letter on Nov 12, 2025 confirming compliance with Listing Rule 5550(a)(2).
- Minimum bid price deficiency now considered closed by Nasdaq.
- No further action required; company remains listed on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315225023444/0001493152-25-023444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315225023444/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-023444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer